Loading...

Major Indexes

Balance Sheet Data

Cleveland BioLabs Inc.

Cleveland BioLabs Inc. (CBLI)

$2.215
0.035 (+1.61%)

Balance Sheet Data

Year
A/P
2013
Projected
2014
Projected
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Total Cash 10.353.1019.6215.258.794.101.582.271.671.230.91
Total Cash (%)
Account Receivables 0.460.270.630.350.550.250.380.130.100.070.05
Account Receivables (%)
Inventories -----------
Inventories (%)
Accounts Payable 0.791.060.200.340.200.140.260.100.080.060.04
Accounts Payable (%)
Capital Expenditure -----------
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.